CEFPIMIZOLE SODIUM

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C28H24N6O10S2.Na.H
Molecular Weight	692.652
Optical Activity	UNSPECIFIED
Defined Stereocenters	3 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[H+].[Na+].[H][C@]12SCC(C[N+]3=CC=C(CCS([O-])(=O)=O)C=C3)=C(N1C(=O)[C@H]2NC(=O)[C@@H](NC(=O)C4=C(NC=N4)C([O-])=O)C5=CC=CC=C5)C([O-])=O

InChI

InChIKey=JLUNZNNMKVKUOH-TZVBBFNXSA-M

InChI=1S/C28H26N6O10S2.Na/c35-23(18(16-4-2-1-3-5-16)31-24(36)19-20(27(38)39)30-14-29-19)32-21-25(37)34-22(28(40)41)17(13-45-26(21)34)12-33-9-6-15(7-10-33)8-11-46(42,43)44;/h1-7,9-10,14,18,21,26H,8,11-13H2,(H5-,29,30,31,32,35,36,38,39,40,41,42,43,44);/q;+1/p-1/t18-,21+,26+;/m0./s1

HIDE SMILES / InChI

Description
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6605719
Curator's Comment: description was created based on several sources, including, http://www.ncbi.nlm.nih.gov/pubmed/3041630, http://www.ncbi.nlm.nih.gov/pubmed/4032736

Cefpimizole is an antibiotic of broad spectrum developed in Japan for the treatment of such conditions as uncomplicated gonorrhea and gynecologic infections. The drug was tested in clinical trials, however, its development was terminated.

Originator

Approval Year

Conditions

Condition	Modality	Targets	Highest Phase	Product
Obstetric and gynecologic infections 2 Sources: http://www.ncbi.nlm.nih.gov/pubmed/4032718	Curative		Phase II 1132	Unknown Approved Use Unknown
Uncomplicated gonorrhea 9 Sources: http://www.ncbi.nlm.nih.gov/pubmed/3041630	Curative		Phase II 1132	Unknown Approved Use Unknown

PubMed

Title	Date	PubMed
Effects of AC-1370, a new semisynthetic cephalosporin, on phagocyte functions.	1983 Jun	6614892
Mechanism of action of AC-1370 on phagocyte functions.	1984 Jan	6703687
Clinical study of cefpimizole in obstetric and gynecologic infections.	1985 Apr	4032718
High-performance liquid chromatography measurement of antimicrobial concentrations in polymorphonuclear leukocytes.	1987 Dec	3439800
Comparison of cefpimizole with cefotaxime and penicillin G for treatment of uncomplicated gonorrhea.	1988 Apr-Jun	3041630

Patents

Sample Use Guides

In Vivo Use Guide

1.0 g of cefpimizole (gonorrea treatment).

Route of Administration: Intramuscular

In Vitro Use Guide

In vitro activity of cefpimizole was tested against C. diversus (MIC 0.4-12.5 ug/ml), H. influenzae (MIC 0.1-0.4 ug/ml), N. gonorrhoeae (MIC 0.1-1.6 ug/ml), Proteus mirabilis (MIC 0.2-12.5 ug/ml), Streptococcus pyogenes (MIC 0.4-3.1 ug/ml), Streptococcus bovis (MIC 1.6-3.1 ug/ml), Streptococcus mitis (MIC 0.2-3.1 ug/ml), Streptococcus agalactiae (MIC 0.8-3.1 ug/ml).

Name

Type

Language

CEFPIMIZOLE SODIUM

Official Name

English

CEFPIMIZOLE SODIUM [USAN]

Common Name

English

CEFPIMIZOLE SODIUM [JAN]

Common Name

English

1-[[(6R,7R)-2-Carboxy-7-[(R)-2-(5-carboxyimidazole-4-carboxamido)-2-phenylacetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-4-(2-sulfoethyl)pyridinium hydroxide, inner salt, monosodium salt

Common Name

English

AJICEF

Brand Name

English

Cefpimizole sodium [WHO-DD]

Common Name

English

PYRIDINIUM, 1-((2-CARBOXY-7-(((((5-CARBOXY-1H-IMIDAZOL-4-YL)CARBONYL)AMINO)PHENYLACETYL)AMINO)-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-EN-3-YL)METHYL)-4-(2-SULFOETHYL)-, HYDROXIDE, INNER SALT, MONOSODIUM SALT, (6R-(6.ALPHA.,7.BETA.(R*)))-

Common Name

English

U-63196E

Code

English

U-63,196E

Code

English

CEFPIMIZOLE SODIUM [MART.]

Common Name

English

CEFPIMIZOLE MONOSODIUM SALT [MI]

Common Name

English

CEFPIMIZOLE MONOSODIUM SALT

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C357